Wrap Technologies (WRAP) director awarded 34,998 stock options at $1.45
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
WRAP TECHNOLOGIES, INC. director John D. Shulman received a grant of stock options covering 34,998 shares of common stock. The options have an exercise price of $1.45 per share, were granted on July 1, 2026, and expire on July 1, 2036. Following this grant, Shulman holds 34,998 stock options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
SHULMAN JOHN D
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 34,998 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 34,998 shares (Direct, null)
Footnotes (1)
Key Figures
Options granted: 34,998 options
Exercise price: $1.45 per share
Expiration date: July 1, 2036
+3 more
6 metrics
Options granted
34,998 options
Stock Option (Right to Buy) grant to director
Exercise price
$1.45 per share
Conversion or exercise price of options
Expiration date
July 1, 2036
Option term end date
Underlying shares
34,998 shares
Common stock underlying the options
Derivative holdings after grant
34,998 options
Total stock options held following transaction
Transaction code
A
Grant, award, or other acquisition
Key Terms
Stock Option (Right to Buy), Common Stock, Grant, award, or other acquisition, derivative securities
4 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
derivative securities financial
"derivativeTransactionCount indicates 1 derivative-type record"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
What insider transaction did WRAP director John D. Shulman report?
John D. Shulman reported receiving a stock option grant for 34,998 shares of WRAP common stock. The options were awarded as a derivative security and give him the right to buy shares at a fixed exercise price.
What is the exercise price of John D. Shulman’s WRAP stock options?
The stock options granted to John D. Shulman have an exercise price of $1.45 per share. This fixed price allows him to acquire WRAP common stock at that level regardless of future market movements during the option term.
When do John D. Shulman’s WRAP stock options expire?
The stock options granted to John D. Shulman are scheduled to expire on July 1, 2036. He can choose to exercise the right to buy the underlying WRAP common shares any time before that expiration date, subject to applicable plan terms.
How many WRAP stock options does John D. Shulman hold after this grant?
After this transaction, John D. Shulman holds 34,998 WRAP stock options directly. This reflects the full size of the new grant reported, with the filing not listing any additional derivative positions remaining beyond this award.
Is John D. Shulman’s WRAP option grant an open-market purchase or a compensation award?
The Form 4 classifies the transaction as a grant or award acquisition, not an open-market purchase. Code “A” and the zero-dollar transaction price indicate these options were awarded to Shulman, typically as part of director compensation.